66 related articles for article (PubMed ID: 1439038)
1. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J
Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of AIDS patients with zidovudine].
Buijs L; Pietersz RN; van den Berg-Wolf MG; Reesink HW; ten Veen JH
Ned Tijdschr Geneeskd; 1990 Jan; 134(2):71-5. PubMed ID: 2296325
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
[TBL] [Abstract][Full Text] [Related]
5. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
Perenboom R; Reiss P; Danner SA; van 't Wout JW
Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis in 7 general hospitals in Andalusia. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
Gómez Camacho E; Cuello JA; Muñoz Lucena F; Pérez Pérez M; Causse M; Torres M; Kindelan JM
Enferm Infecc Microbiol Clin; 1992 May; 10(5):259-66. PubMed ID: 1390994
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
8. Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period.
Blanche S; Duliege AM; Navarette MS; Tardieu M; Debré M; Rouzioux C; Seldrup J; Kouzan S; Griscelli C
Pediatrics; 1991 Aug; 88(2):364-70. PubMed ID: 1861941
[TBL] [Abstract][Full Text] [Related]
9. [Azidothymidine in the management of immune deficiency complex].
Bálint Gábor S
Orv Hetil; 1993 Aug; 134(35):1921-5. PubMed ID: 8361747
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
Cox PH; Martin MA; Styer CM; Beall GN
Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
[TBL] [Abstract][Full Text] [Related]
11. [Long-term follow-up study of 35 children with ADS treated with zidovudine (AZT)].
de José Gómez MI; González de Dios J; Mellado Peña MJ; García Miguel MJ; García Rodríguez MC; Cilleruelo Ortega MJ; Martínez Zapico R; Fernández Calle P; Martín Fontelo P
An Esp Pediatr; 1992 Feb; 36(2):98-108. PubMed ID: 1575412
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine (Retrovir) update.
Rachlis AR
CMAJ; 1990 Dec; 143(11):1177-85. PubMed ID: 2224694
[TBL] [Abstract][Full Text] [Related]
13. [Zidovudine treatment and need of blood transfusion in patients with AIDS].
Ligtenberg PC; Hoepelman IM; Vrehen HM; Borleffs JC
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):130-3. PubMed ID: 2002856
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.
Moore RD; Creagh-Kirk T; Keruly J; Link G; Wang MC; Richman D; Chaisson RE
Arch Intern Med; 1991 May; 151(5):981-6. PubMed ID: 1673837
[TBL] [Abstract][Full Text] [Related]
15. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
[TBL] [Abstract][Full Text] [Related]
17. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment.
Maehlen J; Dunlop O; Liestøl K; Dobloug JH; Goplen AK; Torvik A
AIDS; 1995 Oct; 9(10):1165-9. PubMed ID: 8519453
[TBL] [Abstract][Full Text] [Related]
18. Implications of generalists' slow adoption of zidovudine in clinical practice.
Markson LE; Cosler LE; Turner BJ
Arch Intern Med; 1994 Jul; 154(13):1497-504. PubMed ID: 8018005
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
[TBL] [Abstract][Full Text] [Related]
20. Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection.
Richman DD; Andrews J
Am J Med; 1988 Aug; 85(2A):208-13. PubMed ID: 3044087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
